HOLLY PATTON: Open Payments
NPI 1457933590 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 43 payments from 15 companies in 2025. Trend: 2023 $403 · 2024 $458 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $179 |
| AstraZeneca Pharmaceuticals LP | 11 | $176 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| Lundbeck LLC | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Dexcom, Inc. | 1 | $28 |
| Tris Pharma Inc | 1 | $23 |
Products named: FANAPT, REXULTI, VRAYLAR, BREZTRI, UBRELVY, FARXIGA, AIRSUPRA, QULIPTA.
Industry payments across TX — which companies pay providers there.
